Author

Garrett Lawlor 1

1 Bristol Myers Squibb, Princeton, United

EVALUATION OF OZANIMOD EFFICACY AND SAFETY IN OLDER PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE PHASE 3 TRUE NORTH STUDY

Peter Irving, Ashwin N. Ananthakrishnan, Irina Blumenstein, Sara Horst, HARRIS AHMAD, Garrett Lawlor, Vanessa Hobbs, Anjali Jain, Arteid Memaj, Nabeel Khan

EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Remo Panaccione, Anita Afzali, David P. Hudesman, Garrett Lawlor, Mark T. Osterman, Arteid Memaj, Miguel Regueiro, Subrata Ghosh

RECAPTURE OF RESPONSE WITH OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO WITHDREW THERAPY: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Anita Afzali, Michael Chiorean, Garrett Lawlor, Mark T. Osterman, Arteid Memaj, Remo Panaccione, Subrata Ghosh

Item 1 - 3 / 3
1